Richard J. Davis

Bernard and Shirlee Brown Glaucoma Laboratory, Columbia University

Affiliated withColumbia University Neural Stem Cell Institute

Research Area

Biography

Richard J. Davis has not added Biography.
If you are Richard J. Davis and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 35	2012
Publication title Cited by 17	2017

Other Publications

Article	Year
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. British journal of pharmacology\| PubMed ID: 14744815	2004
Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. European journal of pharmacology\| PubMed ID: 15189770	2004
Expression and functions of the duodenal peptide secretin and its receptor in human lung. American journal of respiratory cell and molecular biology\| PubMed ID: 15191914	2004
M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 15231726	2004
Effective analysis of genomic data. Methods in molecular medicine\| PubMed ID: 15454674	2005
Genetic deletion of CB1 receptors improves non-associative learning. Behavioural brain research\| PubMed ID: 15922076	2005
Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology\| PubMed ID: 16205780	2006
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders. Trends in pharmacological sciences\| PubMed ID: 16260047	2005
The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats. Psychopharmacology\| PubMed ID: 16328376	2006
Mouse Dach2 mutants do not exhibit gross defects in eye development or brain function. Genesis (New York, N.Y. : 2000)\| PubMed ID: 16470613	2006
Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls. Archives of internal medicine\| PubMed ID: 16534037	2006
CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action. Molecular pharmacology\| PubMed ID: 16855179	2006
Exposure to predator odor stress increases efflux of frontal cortex acetylcholine and monoamines in mice: comparisons with immobilization stress and reversal by chlordiazepoxide. Brain research\| PubMed ID: 16919607	2006
Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Neuropharmacology\| PubMed ID: 17433376	2007
Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice. Synapse (New York, N.Y.)\| PubMed ID: 18000809	2008
Mouse Dach1 and Dach2 are redundantly required for MÃ¼llerian duct development. Genesis (New York, N.Y. : 2000)\| PubMed ID: 18395837	2008
Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. American journal of physiology. Gastrointestinal and liver physiology\| PubMed ID: 18653726	2008
Functional rescue of degenerating photoreceptors in mice homozygous for a hypomorphic cGMP phosphodiesterase 6 b allele (Pde6bH620Q). Investigative ophthalmology & visual science\| PubMed ID: 18658088	2008
Role of metabotropic glutamate receptor 5 in the procholinergic effects of neuropsychotherapeutic compounds. Synapse (New York, N.Y.)\| PubMed ID: 18798268	2008
CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology\| PubMed ID: 19116182	2009
Light-dependent phosphorylation of the gamma subunit of cGMP-phophodiesterase (PDE6gamma) at residue threonine 22 in intact photoreceptor neurons. Biochemical and biophysical research communications\| PubMed ID: 19878658	2009
shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. Journal of cellular and molecular medicine\| PubMed ID: 20950332	2011
Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa. Experimental biology and medicine (Maywood, N.J.)\| PubMed ID: 21885480	2011
Effect of the ILE86TER mutation in the Î³ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling. Cellular signalling\| PubMed ID: 21920434	2012
Long-term safety and efficacy of human induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 22895806	2012
Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. PloS one\| PubMed ID: 22970106	2012
Retrospective. Sir Bernard Lovell (1913-2012). Science (New York, N.Y.)\| PubMed ID: 22984062	2012
Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa. Human molecular genetics\| PubMed ID: 23108158	2012